N
Patient 1
THE HIFU DEVICE, SONOBLATE-500 IS UNDER IDE STUDY. THE ADVERSE EVENT IS AN ANTICIPATED EVENT. THE IDE STUDY # (B)(4) IS NOW CLOSED ENROLLING PTS AS IT HAS COMPLETED ALLOWABLE NUMBER FOR THE STUDY.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SONOBLATE-500 | HIGH INTENSITY FOCUSSED ULTRASOUND | FOCUS SURGERY, INC. | MIK | SONOBLATE-500 | Y | * |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2004-09-22 | 0 | 1. R |
Patient 1
THE HIFU DEVICE, SONOBLATE-500 IS UNDER IDE STUDY. THE ADVERSE EVENT IS AN ANTICIPATED EVENT. THE IDE STUDY # (B)(4) IS NOW CLOSED ENROLLING PTS AS IT HAS COMPLETED ALLOWABLE NUMBER FOR THE STUDY.
Patient 1
MR. (B)(6) UNDERWENT HIGH INTENSITY FOCUSED ULTRASOUND TREATMENT OF THE PRO-STATE FOR PERSISTENT PROSTATE CANCER ON (B)(6) 2004. THREE WEEKS POSTOPERATIVELY HE DEVELOPED PROFUSE DIARRHEA AND WAS DIAGNOSED WITH A PROSTATIC RECTO-URETHRAL FISTULA. HE WILL NOW REQUIRE COLOSTOMY AND REPAIR.